title: Intermittent Androgen Deprivation in Prostate Cancer: Are We Ready to Quit?
authors.affiliation: Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
authors.forename: Jong Chul
authors.initials: JC
authors.lastname: Park
authors.affiliation: Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD eisenma@jhmi.edu.
authors.forename: Mario A
authors.initials: MA
authors.lastname: Eisenberger
mesh_terms: D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal